S
Sequent Medical
Sequent Medical - Treating aneurysm with Microbraid technology
About Sequent Medical
Sequent Medical, Inc., established in 2007 by co-founders Brian J. Cox and Bob Rosenbluth, Ph.D., operated as a venture-backed medical device company focused on the neurovascular market. The founders had prior success, having also established MicroVention, Inc., which was later acquired by Terumo. Sequent Medical secured significant venture capital, raising $65.3 million over several funding rounds from investors including Delphi Ventures, USVP, and Versant Ventures, to fuel its development programs.
The company's core business centered on the development, manufacturing, and sale of catheter-based devices for treating cerebral aneurysms. Its flagship product is the WEB® Aneurysm Embolization System, an intrasaccular flow disrupter designed for both ruptured and unruptured intracranial aneurysms. This system is based on the company's proprietary MicroBraid™ technology, which involves a dense mesh constructed from a large number of very fine Nitinol wires. This design allows for a tailored balance of compliance and porosity, bridging the neck of the aneurysm to promote rapid stasis. The WEB system was developed as an alternative for difficult-to-treat aneurysms, such as wide-necked bifurcation aneurysms, offering physicians a less complex, intra-saccular approach.
A significant milestone was achieved in 2010 when the WEB® system received the CE Mark, allowing for its commercial sale in major European markets. By 2016, the device had been used to treat over 3,000 patients in Europe and other regions. The company also initiated multiple clinical studies, including the WEB-IT pivotal trial to support FDA evaluation for the U.S. market and the CLARYS study in Europe to specifically assess the device's performance in ruptured aneurysms. In June 2016, Terumo Corporation announced its acquisition of Sequent Medical for an initial price of $280 million, with an additional $100 million contingent on specific milestones. The acquisition was completed in July 2016, integrating Sequent into Terumo's MicroVention subsidiary to strengthen its global neurovascular product portfolio.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2007
- Headquarters
- Aliso Viejo, United States
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 77.2/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2C
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jun 2016 | $280M | — | Undisclosed | — |
| SERIES DOther financing | Apr 2014 | $20M | $80M | Versant Ventures · Delphi Ventures · Domain Associates | — |
Growth signals
Latest recorded traffic for Sequent Medical is 130 monthly website visits, down 59.4% over the last three months. Sequent Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Sequent Medical in the Aliso Viejo ecosystem
The Sequent Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Domain Associates
Versant Ventures
Series B and later1 investor entered at this stage
Delphi Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sequent Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sequent Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







